These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26509719)

  • 1. Califf for the FDA.
    Drazen JM
    N Engl J Med; 2016 Jan; 374(2):176-7. PubMed ID: 26509719
    [No Abstract]   [Full Text] [Related]  

  • 2. Ex-FDA Chief Robert Califf, MD, Heads to Silicon Valley.
    Abbasi J
    JAMA; 2017 Jul; 318(2):116. PubMed ID: 28697237
    [No Abstract]   [Full Text] [Related]  

  • 3. Margaret A. Hamburg, MD, Reflects on 6 Years at FDA.
    Hamburg MA; Rubin R
    JAMA; 2015 Jun; 313(23):2309-10. PubMed ID: 26080325
    [No Abstract]   [Full Text] [Related]  

  • 4. "Unfinished Business" Brings Robert Califf, MD, Back for a Second Stint as FDA Commissioner.
    Rubin R
    JAMA; 2022 May; 327(20):1946-1948. PubMed ID: 35507365
    [No Abstract]   [Full Text] [Related]  

  • 5. Top FDA official named as 'de facto' chief.
    Wadman M
    Nature; 1997 Feb; 385(6616):476. PubMed ID: 9020347
    [No Abstract]   [Full Text] [Related]  

  • 6. Profile: Susan Wood.
    Wilan K
    Nat Biotechnol; 2007 May; 25(5):495. PubMed ID: 17483824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA law enforcement: critical to product safety.
    Rados C
    FDA Consum; 2006; 40(1):21-7. PubMed ID: 16528823
    [No Abstract]   [Full Text] [Related]  

  • 8. What ails the FDA?
    Okie S
    N Engl J Med; 2005 Mar; 352(11):1063-6. PubMed ID: 15784660
    [No Abstract]   [Full Text] [Related]  

  • 9. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reviving the FDA.
    Okie S
    N Engl J Med; 2010 Oct; 363(16):1492-4. PubMed ID: 20925536
    [No Abstract]   [Full Text] [Related]  

  • 11. New FDA appointment offers food for thought.
    Miller H
    Nat Biotechnol; 1998 Oct; 16(10):886. PubMed ID: 9788324
    [No Abstract]   [Full Text] [Related]  

  • 12. New FDA Commissioner sees challenges, opportunities.
    Lewis C
    FDA Consum; 2003; 37(1):9. PubMed ID: 12625298
    [No Abstract]   [Full Text] [Related]  

  • 13. Robert Califf: controversial new head of the FDA.
    Lenzer J
    BMJ; 2016 Jul; 354():i3656. PubMed ID: 27381843
    [No Abstract]   [Full Text] [Related]  

  • 14. The big gap at the FDA.
    Stipp D
    Fortune; 2002 Jul; 146(2):113-4, 116. PubMed ID: 12141178
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA head Califf spurned.
    Nat Biotechnol; 2016 Mar; 34(3):220. PubMed ID: 26963533
    [No Abstract]   [Full Text] [Related]  

  • 16. Mr. Outside moves inside. Daniel Troy fought the FDA for years; now he's helping to run it.
    Schultz S
    US News World Rep; 2003 Mar; 134(9):63-5. PubMed ID: 12688015
    [No Abstract]   [Full Text] [Related]  

  • 17. Why America needs a strong FDA.
    Markel H
    JAMA; 2005 Nov; 294(19):2489-91. PubMed ID: 16287960
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA appointment is stalled as revelations emerge over Plan B.
    Tanne JH
    BMJ; 2006 Aug; 333(7563):317. PubMed ID: 16902205
    [No Abstract]   [Full Text] [Related]  

  • 19. Missing in action. With no one at the wheel, the FDA has been conspicuously voiceless during the health crisis.
    Schultz S
    US News World Rep; 2001 Nov; 131(21):55. PubMed ID: 11727475
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA centennial.
    Kennedy D
    Science; 2006 Apr; 312(5770):19. PubMed ID: 16601155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.